Cargando…

Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein

Calcium-permeable pores formed by small oligomers of amyloid proteins are the primary pathologic species in Alzheimer’s and Parkinson’s diseases. However, the molecular mechanisms underlying the assembly of these toxic oligomers in the plasma membrane of brain cells remain unclear. Here we have anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Scala, Coralie, Yahi, Nouara, Boutemeur, Sonia, Flores, Alessandra, Rodriguez, Léa, Chahinian, Henri, Fantini, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926208/ https://www.ncbi.nlm.nih.gov/pubmed/27352802 http://dx.doi.org/10.1038/srep28781

Ejemplares similares

Comparison of the amyloid pore forming properties of rat and human Alzheimer’s beta-amyloid peptide 1-42: Calcium imaging data
por: Di Scala, Coralie, et al.
Publicado: (2016)

AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy
por: Azzaz, Fodil, et al.
Publicado: (2023)

AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery
por: Di Scala, Coralie, et al.
Publicado: (2022)

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
por: Fantini, Jacques, et al.
Publicado: (2020)

Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide
por: Yahi, Nouara, et al.
Publicado: (2014)

Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
por: El-Battari, Assou, et al.
Publicado: (2021)

Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases
por: Fantini, Jacques, et al.
Publicado: (2010)

How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ(1-40))
por: Yahi, Nouara, et al.
Publicado: (2010)

Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter
por: Scala, Coralie Di, et al.
Publicado: (2018)

Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation
por: Fantini, Jacques, et al.
Publicado: (2013)

Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
por: Fantini, Jacques, et al.
Publicado: (2021)

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
por: Fantini, Jacques, et al.
Publicado: (2020)

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
por: Yahi, Nouara, et al.
Publicado: (2021)

A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L
por: Fantini, Jacques, et al.
Publicado: (2022)

Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future
por: Fantini, Jacques, et al.
Publicado: (2023)

Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data
por: Di Scala, Coralie, et al.
Publicado: (2017)

Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
por: Fantini, Jacques, et al.
Publicado: (2021)

The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program
por: Azzaz, Fodil, et al.
Publicado: (2022)

Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era
por: Fantini, Jacques, et al.
Publicado: (2023)

Host Membranes as Drivers of Virus Evolution
por: Matveeva, Mélanie, et al.
Publicado: (2023)

Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes
por: Guérin, Patrick, et al.
Publicado: (2022)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2
por: Jaafar, Rita, et al.
Publicado: (2021)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
por: Köppen, Janett, et al.
Publicado: (2020)

Amyloid pores in mitochondrial membranes
por: Vassallo, Neville
Publicado: (2021)

Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2
por: Frutos, Roger, et al.
Publicado: (2022)

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
por: Sepkhanova, I., et al.
Publicado: (2009)

Imaging β amyloid's pore performance
por: Short, Ben
Publicado: (2011)

Analyzing and Modeling the Kinetics of Amyloid Beta Pores Associated with Alzheimer’s Disease Pathology
por: Ullah, Ghanim, et al.
Publicado: (2015)

Partial Peptide of α-Synuclein Modified with Small-Molecule Inhibitors Specifically Inhibits Amyloid Fibrillation of α-Synuclein
por: Yoshida, Wataru, et al.
Publicado: (2013)

Amyloid Peptide Toxicity in an Animal Model of Alzheimer Disease
por: Gross, Liza
Publicado: (2007)

β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
por: Sun, Xiaojuan, et al.
Publicado: (2015)

Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
por: SAIDO, Takaomi C.
Publicado: (2013)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

Alignment of Alzheimer’s disease amyloid β-peptide and klotho
por: LEHRER, STEVEN, et al.
Publicado: (2020)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
por: Boumenir, Adla, et al.
Publicado: (2019)

α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
por: Falke, Marcel, et al.
Publicado: (2019)

Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
por: Ferreira, Sofia, et al.
Publicado: (2020)

The neurotransmitter serotonin interrupts α-synuclein amyloid maturation
por: Falsone, S. Fabio, et al.
Publicado: (2011)

Ganglioside lipids accelerate α-synuclein amyloid formation
por: Gaspar, Ricardo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_or3dobtnc1r1c3m6qpl2rqvvag